Trademark: 79352347
Word
LCLNP
Status Date
Tuesday, May 28, 2024
Registration Number
7393905
Registration Date
Tuesday, May 28, 2024
Filing Date
Monday, July 18, 2022
Published for Opposition
Tuesday, March 12, 2024
5 Lipid-based pharmaceuticals, namely, lipid-based drug delivery vehicle preparations in the form of lipid formulations that facilitate the delivery of pharmaceuticals for the diagnosis, treatment or prevention of diseases and disorders, namely, cancer, infectious diseases, genetic disorders, inflammation and immunological disorders, and for reducing symptoms associated with aging; nucleic acid-based pharmaceuticals, namely, DNA- and RNA-based pharmaceuticals for the diagnosis, treatment or prevention of diseases and disorders, namely, cancers, infectious diseases, genetic disorders, inflammation and immunological disorders and for reducing symptoms associated with aging; small molecule pharmaceuticals for use in the diagnosis, treatment or prevention of cancer, infectious diseases, genetic disorders, inflammation and immunological disorders and for reducing symptoms associated with aging; protein- and peptide-based pharmaceuticals for use in the diagnosis, treatment or prevention of cancer, infectious diseases, genetic disorders, inflammation and immunological disorders and for reducing symptoms associated with aging
42 Pharmaceutical research and development services; pharmaceutical drug development services; providing medical and scientific research information in the field of pharmaceuticals; pharmaceutical formulation development services
Oct 13, 2022
Sn Assigned For Sect 66a Appl From Ib
Oct 14, 2022
New Application Office Supplied Data Entered
Oct 18, 2022
Application Filing Receipt Mailed
Mar 11, 2023
New Representative At Ib Received
May 2, 2023
Assigned To Examiner
Jun 2, 2023
Non-Final Action Written
Jun 3, 2023
Non-Final Action (Ib Refusal) Prepared For Review
Jul 11, 2023
Refusal Processed By Mpu
Jul 11, 2023
Non-Final Action Mailed - Refusal Sent To Ib
Aug 1, 2023
Refusal Processed By Ib
Jan 8, 2024
Teas Response To Office Action Received
Jan 8, 2024
Correspondence Received In Law Office
Jan 9, 2024
Teas/Email Correspondence Entered
Feb 7, 2024
Examiners Amendment -Written
Feb 7, 2024
Examiners Amendment E-Mailed
Feb 7, 2024
Notification Of Examiners Amendment E-Mailed
Feb 7, 2024
Examiner's Amendment Entered
Feb 8, 2024
Approved For Pub - Principal Register
Feb 21, 2024
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Feb 21, 2024
Notification Of Notice Of Publication E-Mailed
Feb 21, 2024
Official Gazette Publication Confirmation E-Mailed
Feb 21, 2024
Notification Of Possible Opposition Sent To Ib
Mar 11, 2024
Notification Processed By Ib
Mar 12, 2024
Published For Opposition
Mar 12, 2024
Official Gazette Publication Confirmation E-Mailed
Mar 13, 2024
Notification Of Possible Opposition Sent To Ib
Mar 13, 2024
Notification Of Possible Opposition Created, To Be Sent To Ib
Apr 1, 2024
Notification Of Possible Opposition - Processed By Ib
May 28, 2024
Registered-Principal Register
May 28, 2024
Notice Of Registration Confirmation Emailed
Aug 28, 2024
Final Disposition Notice Created, To Be Sent To Ib
Trademark Alertz updated from USPTO on 2030-01-24
